WP
LEGN icon

Woodline Partners’s Legend Biotech LEGN Stock Holding History

Woodline Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1M Buy
663,086
+457,216
+222% +$12.3M 0.06% 378
2026
Q1 		$3.72M Buy
205,870
+793
+0.4% +$15.1K 0.01% 711
2025
Q4 		$4.46M Hold
205,077
– – 0.02% 649
2025
Q3 		$6.69M Hold
205,077
– – 0.03% 509
2025
Q2 		$7.28M Buy
205,077
+91,106
+80% +$2.95M 0.04% 488
2025
Q1 		$3.87M Sell
113,971
-6,333
-5% -$227K 0.03% 566
2024
Q4 		$3.91M Buy
120,304
+10,909
+10% +$452K 0.03% 532
2024
Q3 		$5.33M Buy
109,395
+9,394
+9% +$500K 0.04% 381
2024
Q2 		$4.43M Sell
100,001
-6
-0% -$277 0.04% 354
2024
Q1 		$5.61M Buy
100,007
+7
+0% +$422 0.05% 346
2023
Q4 		$6.02M Hold
100,000
– – 0.07% 293
2023
Q3 		$6.72M Sell
100,000
-69,305
-41% -$4.81M 0.08% 272
2023
Q2 		$11.7M Buy
169,305
+37,865
+29% +$2.47M 0.14% 189
2023
Q1 		$6.34M Sell
131,440
-7,527
-5% -$368K 0.09% 259
2022
Q4 		$6.94M Buy
138,967
+7,467
+6% +$362K 0.09% 268
2022
Q3 		$5.37M Sell
131,500
-1,039,551
-89% -$48.8M 0.08% 278
2022
Q2 		$64.4M Hold
1,171,051
– – 0.99% 10
2022
Q1 		$42.6M Sell
1,171,051
-307,615
-21% -$12.2M 0.69% 27
2021
Q4 		$68.9M Buy
1,478,666
+72
+0% +$3.65K 0.99% 16
2021
Q3 		$74.8M Buy
1,478,594
+1,205,551
+442% +$50.2M 1.22% 10
2021
Q2 		$11.2M Buy
+273,043
New +$9.28M 0.21% 124
2021
Q1 		– Sell
-431,418
Closed -$12.1M – 452
2020
Q4 		$12.1M Buy
+431,418
New +$12.4M 0.32% 95
2020
Q3 		– Sell
-193,857
Closed -$8.25M – 197
2020
Q2 		$8.25M Buy
+193,857
New +$7.57M 0.33% 82

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Woodline Partners's LEGN Position: Q2 2026 in Review

Woodline Partners increased its Legend Biotech (LEGN) stake by 222% in Q2 2026, buying an estimated $12.3M and bringing the position to 663,086 shares worth $19.1M. The position accounts for 0.06% of the portfolio, ranked #378.

Woodline Partners first reported a position in LEGN in Q2 2020 and has held it in 23 quarters since. The position peaked at $74.8M in Q3 2021. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Woodline Partners held 663,086 shares of Legend Biotech worth $19.1M as of Q2 2026.
  • Woodline Partners bought 457,216 Legend Biotech shares in Q2 2026, an estimated $12.3M.
  • Legend Biotech made up 0.06% of Woodline Partners's portfolio in Q2 2026, its #378 holding.
  • Woodline Partners first reported a position in Legend Biotech in Q2 2020 and has held it in 23 quarters since.
  • Woodline Partners's Legend Biotech position peaked at $74.8M in Q3 2021.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.